Experiences with
Eltrombopag67 public posts
Want to take advantage of all our features? Just log in!
or
A phase II trial of eltrombopag for patients with CLL and thrombocytopenia
Nov 2018
Eltrombopag is an oral thrombopoietin (TPO)‐receptor agonist that induces proliferation and differentiation of megakaryocytes. Eltrombopag is approved for the treatment of chronic immune thrombocytopenia purpura (ITP) after insufficient response to standard therapy.